FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

769238002: Product containing buprenorphine in transdermal dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3690429013 Product containing buprenorphine in transdermal dosage form (medicinal product form) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3690430015 Buprenorphine in transdermal dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3690431016 Product containing buprenorphine in transdermal dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3708884010 Buprenorphine-containing product in transdermal dose form en Synonym Active Entire term case insensitive SNOMED CT core module
3708885011 Product containing buprenorphine in transdermal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing buprenorphine in transdermal dose form (medicinal product form) Is a Product manufactured as transdermal dose form true Inferred relationship Existential restriction modifier
Product containing buprenorphine in transdermal dose form (medicinal product form) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier 1
Product containing buprenorphine in transdermal dose form (medicinal product form) Is a Product containing buprenorphine true Inferred relationship Existential restriction modifier
Product containing buprenorphine in transdermal dose form (medicinal product form) Has manufactured dose form Transdermal dose form true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely buprenorphine 20 microgram/1 hour prolonged-release transdermal patch (clinical drug) Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Buprenorphine 5microgram/hour transdermal patch Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug) Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch Is a False Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only buprenorphine in transdermal dose form (medicinal product form) Is a True Product containing buprenorphine in transdermal dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start